Pelthos Therapeutics (Formerly Channel Therapeutics): Funding & Investors (Sep 2026)
Pelthos Therapeutics is a biotechnology firm specializing in life sciences of therapeutics and flavours.
Pelthos Therapeutics (Formerly Channel Therapeutics) has raised $48.0M across 2 funding rounds on record, the most recent an undisclosed round of $30.0M announced in Jan 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Pelthos Therapeutics (Formerly Channel Therapeutics) Company Profile and Key Stats
Latest funding round on record: Jan 2026.
Pelthos Therapeutics (Formerly Channel Therapeutics) Funding Rounds
Pelthos Therapeutics (Formerly Channel Therapeutics) raised $18.0M in an undisclosed round announced in Nov 2025.
2 months later, an undisclosed round of $30.0M was announced in Jan 2026.
Pelthos Therapeutics (Formerly Channel Therapeutics) Founders and Leadership Team
No contact details are on record for this team yet.
Pelthos Therapeutics (Formerly Channel Therapeutics) Funding Compared to Other Biotechnology Startups
Pelthos Therapeutics (Formerly Channel Therapeutics)'s latest round of $30.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Pelthos Therapeutics (Formerly Channel Therapeutics) in Biotechnology and Durham
Companies Similar to Pelthos Therapeutics (Formerly Channel Therapeutics)
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Pelthos Therapeutics (Formerly Channel Therapeutics) Funding FAQs
What does Pelthos Therapeutics (Formerly Channel Therapeutics) do?
Pelthos Therapeutics is a biotechnology firm specializing in life sciences of therapeutics and flavours.
How much funding has Pelthos Therapeutics (Formerly Channel Therapeutics) raised?
Pelthos Therapeutics (Formerly Channel Therapeutics) has raised $48.0M across 2 rounds on record. The most recent is an undisclosed round of $30.0M announced in Jan 2026.
When did Pelthos Therapeutics (Formerly Channel Therapeutics) last raise funding?
Pelthos Therapeutics (Formerly Channel Therapeutics)'s most recent funding round on record is an undisclosed round of $30.0M, announced in Jan 2026.
Who founded Pelthos Therapeutics (Formerly Channel Therapeutics)?
FundedIQ lists Christian Kopfli (Founder) at Pelthos Therapeutics (Formerly Channel Therapeutics).
Where is Pelthos Therapeutics (Formerly Channel Therapeutics) headquartered?
Pelthos Therapeutics (Formerly Channel Therapeutics) is based in Durham, North Carolina, United States.
How many employees does Pelthos Therapeutics (Formerly Channel Therapeutics) have?
Pelthos Therapeutics (Formerly Channel Therapeutics) is in the 11-50 employee band.
How does Pelthos Therapeutics (Formerly Channel Therapeutics)'s funding compare to other Biotechnology startups?
Pelthos Therapeutics (Formerly Channel Therapeutics)'s latest round of $30.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Pelthos Therapeutics (Formerly Channel Therapeutics) Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pelthos Therapeutics (Formerly Channel Therapeutics) is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.